PubMed

Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits.

Burke B, Gómez-Román VR, Lian Y, Sun Y, Kan E, Ulmer J, Srivastava IK, Barnett SW.

Virology. 2009 Apr 25;387(1):147-56. Epub 2009 Feb 27.PMID: 19249806 [PubMed - indexed for MEDLINE]Related articles

A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptide.

Martin G, Sun Y, Heyd B, Combes O, Ulmer JB, Descours A, Barnett SW, Srivastava IK, Martin L.

Virology. 2008 Nov 25;381(2):241-50. Epub 2008 Oct 2.PMID: 18835005 [PubMed - indexed for MEDLINE]Related articles

Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.

Caputo A, Brocca-Cofano E, Castaldello A, Voltan R, Gavioli R, Srivastava IK, Barnett SW, Cafaro A, Ensoli B.

Vaccine. 2008 Feb 26;26(9):1214-27. Epub 2008 Jan 15.PMID: 18243435 [PubMed - indexed for MEDLINE]Related articles

Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.

Barnett SW, Srivastava IK, Kan E, Zhou F, Goodsell A, Cristillo AD, Ferrai MG, Weiss DE, Letvin NL, Montefiori D, Pal R, Vajdy M.

AIDS. 2008 Jan 30;22(3):339-48.PMID: 18195560 [PubMed - indexed for MEDLINE]Related articles

Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates.

Srivastava IK, Kan E, Sun Y, Sharma VA, Cisto J, Burke B, Lian Y, Hilt S, Biron Z, Hartog K, Stamatatos L, Diaz-Avalos R, Cheng RH, Ulmer JB, Barnett SW.

Virology. 2008 Mar 15;372(2):273-90. Epub 2007 Dec 3. Erratum in: Virology. 2008 Nov 25;381(2):287. Diaz-Avalos, Ruben [added]. PMID: 18061231 [PubMed - indexed for MEDLINE]Related articles

Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge.

Bråve A, Hinkula J, Cafaro A, Eriksson LE, Srivastava IK, Magnani M, Ensoli B, Barnett SW, Wahren B, Rollman E.

Vaccine. 2007 Sep 28;25(39-40):6882-90. Epub 2007 Jul 27.PMID: 17707956 [PubMed - indexed for MEDLINE]Related articles

Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens.

Derby NR, Gray S, Wayner E, Campogan D, Vlahogiannis G, Kraft Z, Barnett SW, Srivastava IK, Stamatatos L.

Virology. 2007 Sep 30;366(2):433-45. Epub 2007 Jun 8.PMID: 17560621 [PubMed - indexed for MEDLINE]Related articlesFree article

Direct inactivation of human immunodeficiency virus type 1 by a novel small-molecule entry inhibitor, DCM205.

Duong YT, Meadows DC, Srivastava IK, Gervay-Hague J, North TW.

Antimicrob Agents Chemother. 2007 May;51(5):1780-6. Epub 2007 Feb 16.PMID: 17307982 [PubMed - indexed for MEDLINE]Related articlesFree article

Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein.

Xu R, Srivastava IK, Greer CE, Zarkikh I, Kraft Z, Kuller L, Polo JM, Barnett SW, Stamatatos L.

AIDS Res Hum Retroviruses. 2006 Oct;22(10):1022-30.PMID: 17067273 [PubMed - indexed for MEDLINE]Related articles

Role of neutralizing antibodies in protective immunity against HIV.

Srivastava IK, Ulmer JB, Barnett SW.

Hum Vaccin. 2005 Mar-Apr;1(2):45-60. Epub 2005 Mar 17. Review.PMID: 17038830 [PubMed - indexed for MEDLINE]Related articlesFree article

Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.

Burke B, Derby NR, Kraft Z, Saunders CJ, Dai C, Llewellyn N, Zharkikh I, Vojtech L, Zhu T, Srivastava IK, Barnett SW, Stamatatos L.

Virology. 2006 Nov 25;355(2):138-51. Epub 2006 Aug 22.PMID: 16920175 [PubMed - indexed for MEDLINE]Related articles

Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.

Derby NR, Kraft Z, Kan E, Crooks ET, Barnett SW, Srivastava IK, Binley JM, Stamatatos L.

J Virol. 2006 Sep;80(17):8745-62. Erratum in: J Virol. 2007 Feb;81(3):1538. PMID: 16912322 [PubMed - indexed for MEDLINE]Related articlesFree article

Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines.

Sharma VA, Kan E, Sun Y, Lian Y, Cisto J, Frasca V, Hilt S, Stamatatos L, Donnelly JJ, Ulmer JB, Barnett SW, Srivastava IK.

Virology. 2006 Jun 10. [Epub ahead of print]PMID: 16769099 [PubMed - as supplied by publisher]Related articles

Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.

Xu R, Srivastava IK, Kuller L, Zarkikh I, Kraft Z, Fagrouch Z, Letvin NL, Heeney JL, Barnett SW, Stamatatos L.

Virology. 2006 Jun 5;349(2):276-89. Epub 2006 Mar 9.PMID: 16527321 [PubMed - indexed for MEDLINE]Related articles

Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C.

Barnett SW, Srivastava IK, Ulmer JB, Donnelly JJ, Rappuoli R.

Microbes Infect. 2005 Nov;7(14):1386-91. Epub 2005 Sep 20.PMID: 16275150 [PubMed - indexed for MEDLINE]Related articles

Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design.

Srivastava IK, Ulmer JB, Barnett SW.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S33-52. Review.PMID: 15285704 [PubMed - indexed for MEDLINE]Related articles

Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen.

Leung L, Srivastava IK, Kan E, Legg H, Sun Y, Greer C, Montefiori DC, zur Megede J, Barnett SW.

AIDS. 2004 Apr 30;18(7):991-1001.PMID: 15096801 [PubMed - indexed for MEDLINE]Related articles

Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.

Srivastava IK, Stamatatos L, Kan E, Vajdy M, Lian Y, Hilt S, Martin L, Vita C, Zhu P, Roux KH, Vojtech L, C Montefiori D, Donnelly J, Ulmer JB, Barnett SW.

J Virol. 2003 Oct;77(20):11244-59.PMID: 14512572 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene vaccines.

Srivastava IK, Liu MA.

Ann Intern Med. 2003 Apr 1;138(7):550-9. Review.PMID: 12667025 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region.

Srivastava IK, VanDorsten K, Vojtech L, Barnett SW, Stamatatos L.

J Virol. 2003 Feb;77(4):2310-20.PMID: 12551968 [PubMed - indexed for MEDLINE]Related articlesFree article

Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.

Srivastava IK, Stamatatos L, Legg H, Kan E, Fong A, Coates SR, Leung L, Wininger M, Donnelly JJ, Ulmer JB, Barnett SW.

J Virol. 2002 Mar;76(6):2835-47.PMID: 11861851 [PubMed - indexed for MEDLINE]Related articlesFree article

Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites.

Srivastava IK, Morrisey JM, Darrouzet E, Daldal F, Vaidya AB.

Mol Microbiol. 1999 Aug;33(4):704-11.PMID: 10447880 [PubMed - indexed for MEDLINE]Related articles

A mechanism for the synergistic antimalarial action of atovaquone and proguanil.

Srivastava IK, Vaidya AB.

Antimicrob Agents Chemother. 1999 Jun;43(6):1334-9.PMID: 10348748 [PubMed - indexed for MEDLINE]Related articlesFree article

Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite.

Srivastava IK, Rottenberg H, Vaidya AB.

J Biol Chem. 1997 Feb 14;272(7):3961-6.PMID: 9020100 [PubMed - indexed for MEDLINE]Related articlesFree article

Proteins with molecular masses of 25 to 40 kilodaltons elicit optimal protective responses against Plasmodium chabaudi adami infection.

Kima PE, Srivastava IK, Long CA.

Infect Immun. 1992 Dec;60(12):5065-70.PMID: 1452338 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification and purification of glucose phosphate isomerase of Plasmodium falciparum.

Srivastava IK, Schmidt M, Grall M, Certa U, Garcia AM, Perrin LH.

Mol Biochem Parasitol. 1992 Sep;54(2):153-64.PMID: 1435856 [PubMed - indexed for MEDLINE]Related articles

Plasmodium falciparum: identification and purification of the phosphoglycerate kinase of the malaria parasite.

Grall M, Srivastava IK, Schmidt M, Garcia AM, Mauël J, Perrin LH.

Exp Parasitol. 1992 Aug;75(1):10-8.PMID: 1639156 [PubMed - indexed for MEDLINE]Related articles

Comparative evaluation of an ELISA based on recombinant polypeptides and IFA for serology of malaria.

Srivastava IK, Schmidt M, Grall M, Yerly S, Garcia AM, Bouvier M, Takacs B, Dobeli H, Perrin LH.

J Trop Med Hyg. 1991 Jun;94(3):189-94.PMID: 2051524 [PubMed - indexed for MEDLINE]Related articles

Expression, purification, biochemical characterization and inhibition of recombinant Plasmodium falciparum aldolase.

Döbeli H, Trzeciak A, Gillessen D, Matile H, Srivastava IK, Perrin LH, Jakob PE, Certa U.

Mol Biochem Parasitol. 1990 Jun;41(2):259-68.PMID: 2204832 [PubMed - indexed for MEDLINE]Related articles

Specificity and inhibitory activity of antibodies to Plasmodium falciparum aldolase.

Srivastava IK, Schmidt M, Certa U, Döbeli H, Perrin LH.

J Immunol. 1990 Feb 15;144(4):1497-503.PMID: 2406342 [PubMed - indexed for MEDLINE]Related articles

Recombinant polypeptides for serology of malaria.

Srivastava IK, Takacs B, Caspers P, Certa U, McGregor IA, Scaife J, Perrin LH.

Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):317-21.PMID: 2694465 [PubMed - indexed for MEDLINE]Related articles

Specific IgM and IgG antimalarial antibody responses in paired samples from malaria patients.

Gopal K, Srivastava IK, Sinha R, Das SK, Dutta GP, Passey MN, Kudesia M, Agarwal SS.

Indian J Malariol. 1987 Dec;24(2):125-9. No abstract available. PMID: 3330713 [PubMed - indexed for MEDLINE]Related articles

Serology and seroepidemiology of malaria.

Das SK, Srivastava IK, Dutta GP, Agarwal SS.

J Commun Dis. 1985;17(1 Suppl):68-76. No abstract available. PMID: 3831070 [PubMed - indexed for MEDLINE]Related articles

An evaluation of Plasmodium cynomolgi bastianellii and Plasmodium knowlesi antigens in the seroepidemiology of human malaria using indirect haemagglutination test.

Nath A, Srivastava IK, Sinha R, Agarwal SS, Dutta GP.

Indian J Malariol. 1984 Dec;21(2):99-104. No abstract available. PMID: 6536544 [PubMed - indexed for MEDLINE]Related articles

Evaluation of Plasmodium cynomolgi B antigen in enzyme linked immunosorbent assay (ELISA) test for human malaria.

Dutta GP, Srivastava IK, Sharma P, Agarwal SS.

Indian J Malariol. 1984 Dec;21(2):71-8. No abstract available. PMID: 6399263 [PubMed - indexed for MEDLINE]Related articles

Comparative evaluation of Plasmodium knowlesi and P. cynomolgi antigens in the indirect fluorescent antibody test for human malaria.

Agarwal SS, Nath A, Sharma P, Srivastava IK, Dwivedi SR, Dutta GP.

Indian J Med Res. 1983 May;77:616-22. No abstract available. PMID: 6352471 [PubMed - indexed for MEDLINE]Related articles

Enzyme-linked immunosorbent assay test with Plasmodium knowlesi antigen in diagnosis of malaria.

Srivastava IK, Sharma P, Nath A, Agarwal SS, Dutta GP.

Indian J Med Res. 1983 Apr;77:431-6. No abstract available. PMID: 6347882 [PubMed - indexed for MEDLINE]Related articles